Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Shares Outstanding (2013 - 2026)

Xencor (XNCR) posted quarterly Shares Outstanding (Entity) of $74.1 million for Q1 2026, up 4.12% year-over-year from $71.1 million in Q1 2025, and up 3.05% quarter-over-quarter from $71.9 million in Q4 2025.

Analysis

Xencor (XNCR) Shares Outstanding (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Shares Outstanding (Entity) for 14 consecutive years, with $74.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Shares Outstanding (Entity) rose 4.12% year-over-year to $74.1 million; the TTM figure through Mar 2026 stood at $74.1 million (up 4.12% YoY), while the FY2025 annual figure was $71.9 million, up 2.3% from the prior year.
  • Shares Outstanding (Entity) rose to $74.1 million in Q1 2026 per XNCR's latest filing, from $71.9 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $74.1 million in Q1 2026 and bottomed at $59.5 million in Q1 2022.
  • Historically, Shares Outstanding (Entity) has averaged $65.0 million across 5 years, with a median of $61.6 million in 2024.
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) increased 1.08% — and 2025, when it climbed 15.43%.
  • Xencor's Shares Outstanding (Entity) stood at $60.0 million in 2022, then grew by 1.67% to $61.0 million in 2023, then rose by 15.18% to $70.3 million in 2024, then advanced by 2.3% to $71.9 million in 2025, then gained by 3.05% to $74.1 million in 2026.
  • Business Quant data shows XNCR's Shares Outstanding (Entity) at $74.1 million in Q1 2026, $71.9 million in Q4 2025, and $71.3 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 61.30 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 210.89 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 445.06 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 217.35 Mn
10 Xencor 2.02 Bn 1.65 Bn - 75.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 75.86 Mn
Mar 31, 2026 75.25 Mn
Dec 31, 2025 74.24 Mn
Sep 30, 2025 74.41 Mn
Jun 30, 2025 74.28 Mn
Mar 31, 2025 73.67 Mn
Dec 31, 2024 65.04 Mn
Sep 30, 2024 64.02 Mn
Jun 30, 2024 61.68 Mn
Mar 31, 2024 61.21 Mn
Dec 31, 2023 60.50 Mn
Sep 30, 2023 60.62 Mn
Jun 30, 2023 59.81 Mn
Mar 31, 2023 59.77 Mn
Dec 31, 2022 59.65 Mn
Sep 30, 2022 59.72 Mn
Jun 30, 2022 59.57 Mn
Mar 31, 2022 59.41 Mn
Dec 31, 2021 58.38 Mn
Sep 30, 2021 58.35 Mn